{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:42:53Z","timestamp":1787496173219,"version":"build-2736575974"},"reference-count":234,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0483","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T22:08:21Z","timestamp":1766700501000},"page":"495-516","source":"Crossref","is-referenced-by-count":2,"title":["Anti-aging effects of the adrenal androgens dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanisms of action and beneficial effects in older people"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4166-9493","authenticated-orcid":false,"given":"Hajime","family":"Nawata","sequence":"first","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka 812-8582, Japan"},{"name":"Seiwakai Muta Hospital, Fukuoka 814-0163, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yanase","sequence":"additional","affiliation":[{"name":"Seiwakai Muta Hospital, Fukuoka 814-0163, Japan"},{"name":"Department of Endocrinology and Diabetes Mellitus, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichirou","family":"Morohashi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Kyushu University, Fukuoka 812-8582, Japan"},{"name":"Department of Medicine, Kurume University, Kurume 830-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kurume University, Kurume 830-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Muta","sequence":"additional","affiliation":[{"name":"Seiwakai Muta Hospital, Fukuoka 814-0163, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Butenandt A, Danenbaum H (1934) \u00dcber Androsteron. III. Isolierung eines neuen, physiologisch unwirksamen Sterinderivates aus M\u00e4nnerharn, seine Verkn\u00fcpfung mit Dehydro-androsteron und Androsteron: ein Beitrag zur Konstitution des Androsterons. Z Physiol Chem 229: 192\u2013195 (In German).","DOI":"10.1515\/bchm2.1934.229.4-6.192"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Munson PL, Gallagher TF, Koch FC (1944) Isolation of dehydroepiandrosterone sulfate from normal male urine. J Biol Chem 152: 67\u201377.","DOI":"10.1016\/S0021-9258(18)72091-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Migeon CJ, Keller AR, Lawrence B, Shepard TH, 2nd (1957) Dehydroepiandrosterone and androsterone levels in human plasma: effect of age and sex; day-to-day and diurnal variations. J Clin Endocrinol Metab 17: 1051\u20131062.","DOI":"10.1210\/jcem-17-9-1051"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Sekihara H, Osawa N, Ibayashi H (1972) A radioimmunoassay for serum dehydroepiandrosterone sulfate. Steroids 20: 813\u2013824.","DOI":"10.1016\/0039-128X(72)90059-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Yamaji T, Ibayashi H (1969) Plasma dehydroepiandrosterone sulfate in normal and pathological conditions. J Clin Endocrinol Metab 29: 273\u2013278.","DOI":"10.1210\/jcem-29-2-273"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59: 551\u2013555.","DOI":"10.1210\/jcem-59-3-551"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Nawata H, Yanase T, Goto K, Okabe T, Ashida K (2002) Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mech Ageing Dev 123: 1101\u20131106.","DOI":"10.1016\/S0047-6374(01)00393-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Nawata H, Yanase T, Goto K, Okabe T, Nomura M, et al. (2004) Adrenopause. Horm Res 62 Suppl 3: 110\u2013114.","DOI":"10.1159\/000080509"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Campbell B (2006) Adrenarche and the evolution of human life history. Am J Hum Biol 18: 569\u2013589.","DOI":"10.1002\/ajhb.20528"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Zhai G, Teumer A, Stolk L, Perry JR, Vandenput L, et al. (2011) Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet 7: e1002025.","DOI":"10.1371\/journal.pgen.1002025"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Ruth KS, Campbell PJ, Chew S, Lim EM, Hadlow N, et al. (2016) Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. Eur J Hum Genet 24: 284\u2013290.","DOI":"10.1038\/ejhg.2015.102"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Oishi Y, Manabe I (2018) Kr\u00fcppel-Like factors in metabolic homeostasis and cardiometabolic disease. Front Cardiovasc Med 5: 69.","DOI":"10.3389\/fcvm.2018.00069"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Smit P, van Schaik RH, van der Werf M, van den Beld AW, Koper JW, et al. (2005) A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 90: 5313\u20135316.","DOI":"10.1210\/jc.2005-0307"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153: 1194\u20131217.","DOI":"10.1016\/j.cell.2013.05.039"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Schwartz AG, Pashko LL (2004) Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Res Rev 3: 171\u2013187.","DOI":"10.1016\/j.arr.2003.05.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W (1994) Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 131: 99\u2013104.","DOI":"10.1007\/BF00925945"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kr\u00f8ll J (2015) Dehydroepiandrosterone, molecular chaperones and the epigenetics of primate longevity. Rejuvenation Res 18: 341\u2013346.","DOI":"10.1089\/rej.2014.1641"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Prough RA, Clark BJ, Klinge CM (2016) Novel mechanisms for DHEA action. J Mol Endocrinol 56: R139\u2013R155.","DOI":"10.1530\/JME-16-0013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Labrie F (2015) All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. J Steroid Biochem Mol Biol 145: 133\u2013138.","DOI":"10.1016\/j.jsbmb.2014.06.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Labrie F (2010) DHEA, important source of sex steroids in men and even more in women. Prog Brain Res 182: 97\u2013148.","DOI":"10.1016\/S0079-6123(10)82004-7"},{"key":"21","unstructured":"21 Baulieu EE (1997) Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52: 1\u201332."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Morales AJ, Nolan JJ, Nelson JC, Yen SS (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78: 1360\u20131367.","DOI":"10.1210\/jcem.78.6.7515387"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23 Villareal DT, Holloszy JO (2004) Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292: 2243\u20132248.","DOI":"10.1001\/jama.292.18.2243"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Weiss EP, Villareal DT, Fontana L, Han DH, Holloszy JO (2011) Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging (Albany NY) 3: 533\u2013542.","DOI":"10.18632\/aging.100327"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Yamada Y, Sekihara H, Omura M, Yanase T, Takayanagi R, et al. (2007) Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons. Endocr J 54: 153\u2013162.","DOI":"10.1507\/endocrj.K05-132"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Samaras N, Samaras D, Frangos E, Forster A, Philippe J (2013) A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res 16: 285\u2013294.","DOI":"10.1089\/rej.2013.1425"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Bergthorsdottir R, Leonsson-Zachrisson M, Od\u00e9n A, Johannsson G (2006) Premature mortality in patients with Addison\u2019s disease: a population-based study. J Clin Endocrinol Metab 91: 4849\u20134853.","DOI":"10.1210\/jc.2006-0076"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Thornton JW (2001) Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci U S A 98: 5671\u20135676.","DOI":"10.1073\/pnas.091553298"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Eick GN, Thornton JW (2011) Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Mol Cell Endocrinol 334: 31\u201338.","DOI":"10.1016\/j.mce.2010.09.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Baker ME (2004) Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors. Mol Cell Endocrinol 215: 55\u201362.","DOI":"10.1016\/j.mce.2003.11.007"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Baker ME (2011) Insights from the structure of estrogen receptor into the evolution of estrogens: implications for endocrine disruption. Biochem Pharmacol 82: 1\u20138.","DOI":"10.1016\/j.bcp.2011.03.008"},{"key":"32","unstructured":"32 Nawata H, Goto K, Morinaga H, Yanase T, Yanagisawa J, et al. (2002) Molecular mechanisms underlying the action of environmental endocrine-disrupting chemicals. Environmental Sci 9: 57\u201370."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Sorwell KG, Kohama SG, Urbanski HF (2014) Testosterone increases circulating dehydroepiandrosterone sulfate levels in the male rhesus macaque. Front Endocrinol (Lausanne) 5: 101.","DOI":"10.3389\/fendo.2014.00101"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Rege J, Garber S, Conley AJ, Elsey RM, Turcu AF, et al. (2019) Circulating 11-oxygenated androgens across species. J Steroid Biochem Mol Biol 190: 242\u2013249.","DOI":"10.1016\/j.jsbmb.2019.04.005"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35 Roth GS, Lane MA, Ingram DK, Mattison JA, Elahi D, et al. (2002) Biomarkers of caloric restriction may predict longevity in humans. Science 297: 811.","DOI":"10.1126\/science.1071851"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Enomoto M, Adachi H, Fukami A, Furuki K, Satoh A, et al. (2008) Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study). J Am Geriatr Soc 56: 994\u2013998.","DOI":"10.1111\/j.1532-5415.2008.01692.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Imura H (2013) Life course health care and preemptive approach to non-communicable diseases. Proc Jpn Acad Ser B Phys Biol Sci 89: 462\u2013473.","DOI":"10.2183\/pjab.89.462"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38 Kenyon CJ (2010) The genetics of ageing. Nature 464: 504\u2013512.","DOI":"10.1038\/nature08980"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Mattison JA, Colman RJ, Beasley TM, Allison DB, Kemnitz JW, et al. (2017) Caloric restriction improves health and survival of rhesus monkeys. Nat Commun 8: 14063.","DOI":"10.1038\/ncomms14063"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Willcox BJ, Willcox DC, Todoriki H, Fujiyoshi A, Yano K, et al. (2007) Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world\u2019s longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci 1114: 434\u2013455.","DOI":"10.1196\/annals.1396.037"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Redman LM, Ravussin E (2009) Endocrine alterations in response to calorie restriction in humans. Mol Cell Endocrinol 299: 129\u2013136.","DOI":"10.1016\/j.mce.2008.10.014"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Radford DJ, Wang K, McNelis JC, Taylor AE, Hechenberger G, et al. (2010) Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation. Mol Endocrinol 24: 813\u2013821.","DOI":"10.1210\/me.2009-0390"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Tsuji K, Furutama D, Tagami M, Ohsawa N (1999) Specific binding and effects of dehydroepiandrosterone sulfate (DHEA-S) on skeletal muscle cells: possible implication for DHEA-S replacement therapy in patients with myotonic dystrophy. Life Sci 65: 17\u201326.","DOI":"10.1016\/S0024-3205(99)00215-5"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Twede V, Tartaglia AL, Covey DF, Bamber BA (2007) The neurosteroids dehydroepiandrosterone sulfate and pregnenolone sulfate inhibit the UNC-49 GABA receptor through a common set of residues. Mol Pharmacol 72: 1322\u20131329.","DOI":"10.1124\/mol.107.034058"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Bertoni A, Rastoldo A, Sarasso C, Di Vito C, Sampietro S, et al. (2012) Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation. Steroids 77: 260\u2013268.","DOI":"10.1016\/j.steroids.2011.12.010"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Omura T (2011) Recollection of the early years of the research on cytochrome P450. Proc Jpn Acad Ser B Phys Biol Sci 87: 617\u2013640.","DOI":"10.2183\/pjab.87.617"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Fukami M, Homma K, Hasegawa T, Ogata T (2013) Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development. Dev Dyn 242: 320\u2013329.","DOI":"10.1002\/dvdy.23892"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Turcu AF, Nanba AT, Auchus RJ (2018) The rise, fall, and resurrection of 11-oxygenated androgens in human physiology and disease. Horm Res Paediatr 89: 284\u2013291.","DOI":"10.1159\/000486036"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, et al. (1992) The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42: 293\u2013304.","DOI":"10.1016\/0960-0760(92)90132-3"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Okabe T, Haji M, Takayanagi R, Adachi M, Imasaki K, et al. (1995) Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J Clin Endocrinol Metab 80: 2993\u20132996.","DOI":"10.1210\/jcem.80.10.7559886"},{"key":"51","unstructured":"51 Hampl R, Lapc\u00edk O, Hill M, Klak J, Kasal A, et al. (2000) 7-Hydroxydehydroepiandrosterone\u2014a natural antiglucocorticoid and a candidate for steroid replacement therapy? Physiol Res 49 Suppl 1: S107\u2013S112."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Niro S, Hennebert O, Morfin R (2010) New insights into the protective effects of DHEA1). Horm Mol Biol Clin Investig 4: 489\u2013498.","DOI":"10.1515\/HMBCI.2010.050"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Smith DF, Toft DO (2008) Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions. Mol Endocrinol 22: 2229\u20132240.","DOI":"10.1210\/me.2008-0089"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Zannas AS, Wiechmann T, Gassen NC, Binder EB (2016) Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology 41: 261\u2013274.","DOI":"10.1038\/npp.2015.235"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Liu D, Dillon JS (2002) Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem 277: 21379\u201321388.","DOI":"10.1074\/jbc.M200491200"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Liu D, Iruthayanathan M, Homan LL, Wang Y, Yang L, et al. (2008) Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1\/2-mediated mechanisms. Endocrinology 149: 889\u2013898.","DOI":"10.1210\/en.2007-1125"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, et al. (2003) Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 88: 3190\u20133195.","DOI":"10.1210\/jc.2002-021603"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Williams MR, Ling S, Dawood T, Hashimura K, Dai A, et al. (2002) Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87: 176\u2013181.","DOI":"10.1210\/jcem.87.1.8161"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Chen J, Xu L, Huang C (2014) DHEA inhibits vascular remodeling following arterial injury: a possible role in suppression of inflammation and oxidative stress derived from vascular smooth muscle cells. Mol Cell Biochem 388: 75\u201384.","DOI":"10.1007\/s11010-013-1900-7"},{"key":"60","doi-asserted-by":"publisher","unstructured":"60 Taniguchi S, Yanase T, Kobayashi K, Takayanagi R, Nawata H (1996) Dehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-1 cells. Atherosclerosis 126: 143\u2013154.","DOI":"10.1016\/0021-9150(96)05902-3"},{"key":"61","doi-asserted-by":"publisher","unstructured":"61 Yoshida S, Aihara K, Azuma H, Uemoto R, Sumitomo-Ueda Y, et al. (2010) Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function. Atherosclerosis 212: 310\u2013315.","DOI":"10.1016\/j.atherosclerosis.2010.05.011"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Weiss EP, Villareal DT, Ehsani AA, Fontana L, Holloszy JO (2012) Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness. Aging Cell 11: 876\u2013884.","DOI":"10.1111\/j.1474-9726.2012.00852.x"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK, Ljunggren O, et al. (2010) Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J Clin Endocrinol Metab 95: 4406\u20134414.","DOI":"10.1210\/jc.2010-0760"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Wu TT, Chen Y, Zhou Y, Adi D, Zheng YY, et al. (2017) Prognostic value of dehydroepiandrosterone sulfate for patients with cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc 6: e004896.","DOI":"10.1161\/JAHA.116.004896"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Teng Y, Radde BN, Litchfield LM, Ivanova MM, Prough RA, et al. (2015) Dehydroepiandrosterone activation of g-protein-coupled estrogen receptor rapidly stimulates microRNA-21 transcription in human hepatocellular carcinoma cells. J Biol Chem 290: 15799\u201315811.","DOI":"10.1074\/jbc.M115.641167"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Teng Y, Litchfield LM, Ivanova MM, Prough RA, Clark BJ, et al. (2014) Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor \u03b2 and androgen receptor. Mol Cell Endocrinol 392: 23\u201336.","DOI":"10.1016\/j.mce.2014.05.007"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Lazaridis I, Charalampopoulos I, Alexaki VI, Avlonitis N, Pediaditakis I, et al. (2011) Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS Biol 9: e1001051.","DOI":"10.1371\/journal.pbio.1001051"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Marx CE, Jarskog LF, Lauder JM, Gilmore JH, Lieberman JA, et al. (2000) Neurosteroid modulation of embryonic neuronal survival <i>in vitro<\/i> following anoxia. Brain Res 871: 104\u2013112.","DOI":"10.1016\/S0006-8993(00)02452-5"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Suzuki M, Wright LS, Marwah P, Lardy HA, Svendsen CN (2004) Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc Natl Acad Sci U S A 101: 3202\u20133207.","DOI":"10.1073\/pnas.0307325101"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Pediaditakis I, Iliopoulos I, Theologidis I, Delivanoglou N, Margioris AN, et al. (2015) Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors. Endocrinology 156: 16\u201323.","DOI":"10.1210\/en.2014-1596"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Laurine E, Lafitte D, Gr\u00e9goire C, S\u00e9r\u00e9e E, Loret E, et al. (2003) Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. J Biol Chem 278: 29979\u201329986.","DOI":"10.1074\/jbc.M303242200"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 Brown RC, Cascio C, Papadopoulos V (2000) Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J Neurochem 74: 847\u2013859.","DOI":"10.1046\/j.1471-4159.2000.740847.x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73 Tamagno E, Guglielmotto M, Bardini P, Santoro G, Davit A, et al. (2003) Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress. Neurobiol Dis 14: 291\u2013301.","DOI":"10.1016\/S0969-9961(03)00131-1"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Weill-Engerer S, David JP, Sazdovitch V, Liere P, Eychenne B, et al. (2002) Neurosteroid quantification in human brain regions: comparison between Alzheimer\u2019s and nondemented patients. J Clin Endocrinol Metab 87: 5138\u20135143.","DOI":"10.1210\/jc.2002-020878"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Yanase T, Fukahori M, Taniguchi S, Nishi Y, Sakai Y, et al. (1996) Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer\u2019s disease and in cerebrovascular dementia. Endocr J 43: 119\u2013123.","DOI":"10.1507\/endocrj.43.119"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76 Pan X, Wu X, Kaminga AC, Wen SW, Liu A (2019) Dehydroepiandrosterone and dehydroepiandrosterone sulfate in Alzheimer\u2019s disease: a systematic review and meta-analysis. Front Aging Neurosci 11: 61.","DOI":"10.3389\/fnagi.2019.00061"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77 Maggio M, De Vita F, Fisichella A, Colizzi E, Provenzano S, et al. (2015) DHEA and cognitive function in the elderly. J Steroid Biochem Mol Biol 145: 281\u2013292.","DOI":"10.1016\/j.jsbmb.2014.03.014"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78 Yanase T, Muta K, Nawata H (2006) Serum concentrations of dehydroepiandrosterone sulfate (DHEA-S) in oldest old Japanese women correlate with cognitive activity rather than activities of dayly living. Geriatr Gerontrol Int 6: 194\u2013198.","DOI":"10.1111\/j.1447-0594.2006.00346.x"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Yamada S, Akishita M, Fukai S, Ogawa S, Yamaguchi K, et al. (2010) Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment. Geriatr Gerontol Int 10: 280\u2013287.","DOI":"10.1111\/j.1447-0594.2010.00625.x"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80 Topor LS, Asai M, Dunn J, Majzoub JA (2011) Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2. J Clin Endocrinol Metab 96: E31\u2013E39.","DOI":"10.1210\/jc.2010-0692"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81 Nawata H, Higuchi K, Yanase T, Takayanagi R, Kato K, et al. (1985) Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing\u2019s syndrome. Endocrinol Jpn 32: 691\u2013700.","DOI":"10.1507\/endocrj1954.32.691"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82 Sakai Y, Yanase T, Takayanagi R, Nakao R, Nishi Y, et al. (1993) High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing\u2019s syndrome associated with high secretion of adrenal androgens. J Clin Endocrinol Metab 76: 1286\u20131290.","DOI":"10.1210\/jcem.76.5.8496319"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83 Sakai Y, Yanase T, Hara T, Takayanagi R, Haji M, et al. (1994) Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab 78: 36\u201340.","DOI":"10.1210\/jcem.78.1.8288710"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84 Yanase T, Sasano H, Yubisui T, Sakai Y, Takayanagi R, et al. (1998) Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing\u2019s syndrome. Endocr J 45: 89\u201395.","DOI":"10.1507\/endocrj.45.89"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85 Sakai Y, Yanase T, Hara T, Takayanagi R, Haji M, et al. (1994) <i>In-vitro<\/i> evidence for the regulation of 17,20-lyase activity by cytochrome b5 in adrenocortical adenomas from patients with Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 40: 205\u2013209.","DOI":"10.1111\/j.1365-2265.1994.tb02469.x"},{"key":"86","doi-asserted-by":"publisher","unstructured":"86 Nguyen AD, Corbin CJ, Pattison JC, Bird IM, Conley AJ (2009) The developmental increase in adrenocortical 17,20-lyase activity (biochemical adrenarche) is driven primarily by increasing cytochrome b5 in neonatal rhesus macaques. Endocrinology 150: 1748\u20131756.","DOI":"10.1210\/en.2008-1303"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87 Rainey WE, Carr BR, Sasano H, Suzuki T, Mason JI (2002) Dissecting human adrenal androgen production. Trends Endocrinol Metab 13: 234\u2013239.","DOI":"10.1016\/S1043-2760(02)00609-4"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88 Baquedano MS, Berensztein E, Saraco N, Dorn GV, de Davila MT, et al. (2005) Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Pediatr Res 58: 451\u2013458.","DOI":"10.1203\/01.PDR.0000179392.59060.93"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89 Campbell B (2020) DHEAS and human development: an evolutionary perspective. Front Endocrinol (Lausanne) 11: 101.","DOI":"10.3389\/fendo.2020.00101"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90 Corval\u00e1n C, Uauy R, Mericq V (2013) Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 y in Chilean children of normal birth weight. Am J Clin Nutr 97: 318\u2013325.","DOI":"10.3945\/ajcn.112.037325"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91 Kim SH, Moon JY, Sasano H, Choi MH, Park MJ (2016) Body fat mass is associated with ratio of steroid metabolites reflecting 17,20-lyase activity in prepubertal girls. J Clin Endocrinol Metab 101: 4653\u20134660.","DOI":"10.1210\/jc.2016-2515"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92 Biason-Lauber A, Zachmann M, Schoenle EJ (2000) Effect of leptin on CYP17 enzymatic activities in human adrenal cells: new insight in the onset of adrenarche. Endocrinology 141: 1446\u20131454.","DOI":"10.1210\/en.141.4.1446"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93 Nguyen TV, McCracken JT, Ducharme S, Cropp BF, Botteron KN, et al. (2013) Interactive effects of dehydroepiandrosterone and testosterone on cortical thickness during early brain development. J Neurosci 33: 10840\u201310848.","DOI":"10.1523\/JNEUROSCI.5747-12.2013"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94 Yang L, Suwa T, Wright WE, Shay JW, Hornsby PJ (2001) Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells. Mech Ageing Dev 122: 1685\u20131694.","DOI":"10.1016\/S0047-6374(01)00280-9"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95 Hornsby PJ (2002) Aging of the human adrenal cortex. Ageing Res Rev 1: 229\u2013242.","DOI":"10.1016\/S1568-1637(01)00007-1"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96 Mitani F, Mukai K, Miyamoto H, Suematsu M, Ishimura Y (2003) The undifferentiated cell zone is a stem cell zone in adult rat adrenal cortex. Biochim Biophys Acta 1619: 317\u2013324.","DOI":"10.1016\/S0304-4165(02)00490-7"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97 Else T (2009) Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis, and aging. J Mol Endocrinol 43: 131\u2013141.","DOI":"10.1677\/JME-08-0189"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98 Meimaridou E, Kowalczyk J, Guasti L, Hughes CR, Wagner F, et al. (2012) Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat Genet 44: 740\u2013742.","DOI":"10.1038\/ng.2299"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99 Prasad R, Chan LF, Hughes CR, Kaski JP, Kowalczyk JC, et al. (2014) Thioredoxin reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J Clin Endocrinol Metab 99: E1556\u2013E1563.","DOI":"10.1210\/jc.2013-3844"},{"key":"100","doi-asserted-by":"publisher","unstructured":"100 Takayanagi R, Kato K, Ibayashi H (1986) Relative inactivation of steroidogenic enzyme activities of <i>in vitro<\/i> vitamin E-depleted human adrenal microsomes by lipid peroxidation. Endocrinology 119: 464\u2013469.","DOI":"10.1210\/endo-119-2-464"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101 Dharia S, Slane A, Jian M, Conner M, Conley AJ, et al. (2005) Effects of aging on cytochrome b5 expression in the human adrenal gland. J Clin Endocrinol Metab 90: 4357\u20134361.","DOI":"10.1210\/jc.2005-0017"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102 Nawata H, Ou L, Zhang X, Song Q, Huang J, et al. (2025) Arterial stiffness, high fasting glucose, and fatty liver as risk factors for visceral obesity in middle-aged Chinese individuals: a cross-sectional study. Endocr J 72: 525\u2013533.","DOI":"10.1507\/endocrj.EJ24-0554"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103 Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, et al. (2014) Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 349: g4227.","DOI":"10.1136\/bmj.g4227"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104 Liu H, Zhou G, Chen Q, Ouyang F, Little J, et al. (2017) Impact of dehydroepiandrosterone sulfate on newborn leukocyte telomere length. Sci Rep 7: 42160.","DOI":"10.1038\/srep42160"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105 Iwasaki Y, Asai M, Yoshida M, Nigawara T, Kambayashi M, et al. (2004) Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J Clin Endocrinol Metab 89: 3449\u20133454.","DOI":"10.1210\/jc.2003-031441"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106 Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, et al. (2003) Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14: S227\u2013S232.","DOI":"10.1097\/01.ASN.0000077407.90309.65"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107 Brignardello E, Runzo C, Aragno M, Catalano MG, Cassader M, et al. (2007) Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients. Diabetes Care 30: 2922\u20132927.","DOI":"10.2337\/dc07-1110"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108 Jacob MH, Janner Dda R, Ara\u00fajo AS, Jahn MP, Kucharski LC, et al. (2011) Dehydroepiandrosterone improves hepatic antioxidant reserve and stimulates Akt signaling in young and old rats. J Steroid Biochem Mol Biol 127: 331\u2013336.","DOI":"10.1016\/j.jsbmb.2011.07.007"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109 Ding X, Yu L, Ge C, Ma H (2017) Protective effect of DHEA on hydrogen peroxide-induced oxidative damage and apoptosis in primary rat Leydig cells. Oncotarget 8: 16158\u201316169.","DOI":"10.18632\/oncotarget.15300"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110 Freund A, Patil CK, Campisi J (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 30: 1536\u20131548.","DOI":"10.1038\/emboj.2011.69"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111 Jurk D, Wilson C, Passos JF, Oakley F, Correia-Melo C, et al. (2014) Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun 2: 4172.","DOI":"10.1038\/ncomms5172"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112 Alimbetov D, Davis T, Brook AJ, Cox LS, Faragher RG, et al. (2016) Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2. Biogerontology 17: 305\u2013315.","DOI":"10.1007\/s10522-015-9610-z"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113 Huang J, Liu C, Ming XF, Yang Z (2020) Inhibition of p38mapk reduces adipose tissue inflammation in aging mediated by arginase-II. Pharmacology 105: 491\u2013504.","DOI":"10.1159\/000507635"},{"key":"114","doi-asserted-by":"publisher","unstructured":"114 Maciel-Bar\u00f3n L, Morales-Rosales SL, Silva-Palacios A, Rodr\u00edguez-Barrera RH, Garc\u00eda-\u00c1lvarez JA, et al. (2018) The secretory phenotype of senescent astrocytes isolated from Wistar newborn rats changes with anti-inflammatory drugs, but does not have a short-term effect on neuronal mitochondrial potential. Biogerontology 19: 415\u2013433.","DOI":"10.1007\/s10522-018-9767-3"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115 Zhao J, Cao J, Yu L, Ma H (2019) Dehydroepiandrosterone alleviates E. Coli O157:H7-induced inflammation by preventing the activation of p38 MAPK and NF-\u03baB pathways in mice peritoneal macrophages. Mol Immunol 114: 114\u2013122.","DOI":"10.1016\/j.molimm.2019.07.013"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116 Ashida K, Goto K, Zhao Y, Okabe T, Yanase T, et al. (2005) Dehydroepiandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase. Biochim Biophys Acta 1728: 84\u201394.","DOI":"10.1016\/j.bbaexp.2005.01.016"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117 Watanabe T, Ashida K, Goto K, Nawata H, Takayanagi R, et al. (2015) Dehydroepiandrosterone-enhanced dual specificity protein phosphatase (DDSP) prevents diet-induced and genetic obesity. Biochem Biophys Res Commun 468: 196\u2013201.","DOI":"10.1016\/j.bbrc.2015.10.131"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118 Racchi M, Buoso E, Ronfani M, Serafini MM, Galasso M, et al. (2017) Role of hormones in the regulation of RACK1 expression as a signaling checkpoint in immunosenescence. Int J Mol Sci 18: 1453.","DOI":"10.3390\/ijms18071453"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119 Feh\u00e9r T, Bodrogi L (1982) A comparative study of steroid concentrations in human adipose tissue and the peripheral circulation. Clin Chim Acta 126: 135\u2013141.","DOI":"10.1016\/0009-8981(82)90029-8"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120 Taniguchi S, Yanase T, Haji M, Ishibashi K, Takayanagi R, et al. (1995) The antiobesity effect of dehydroepiandrosterone in castrated or noncastrated obese Zucker male rats. Obes Res 3 Suppl 5: 639s\u2013643s.","DOI":"10.1002\/j.1550-8528.1995.tb00480.x"},{"key":"121","doi-asserted-by":"crossref","unstructured":"121 Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, et al. (2008) Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT\/enhancer-binding protein-beta. Mol Endocrinol 22: 2049\u20132060.","DOI":"10.1210\/me.2007-0489"},{"key":"122","doi-asserted-by":"publisher","unstructured":"122 Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166\u20132170.","DOI":"10.1126\/science.1066285"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123 McNelis JC, Manolopoulos KN, Gathercole LL, Bujalska IJ, Stewart PM, et al. (2013) Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake. Am J Physiol Endocrinol Metab 305: E1134\u2013E1144.","DOI":"10.1152\/ajpendo.00314.2012"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124 Tagawa N, Minamitani E, Yamaguchi Y, Kobayashi Y (2011) Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue. Steroids 76: 1546\u20131553.","DOI":"10.1016\/j.steroids.2011.09.005"},{"key":"125","doi-asserted-by":"crossref","unstructured":"125 Aouadi M, Jager J, Laurent K, Gonzalez T, Cormont M, et al. (2007) p38MAP Kinase activity is required for human primary adipocyte differentiation. FEBS Lett 581: 5591\u20135596.","DOI":"10.1016\/j.febslet.2007.10.064"},{"key":"126","doi-asserted-by":"crossref","unstructured":"126 Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, et al. (2011) Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 13: 170\u2013182.","DOI":"10.1016\/j.cmet.2011.01.001"},{"key":"127","doi-asserted-by":"crossref","unstructured":"127 Ceci R, Duranti G, Rossi A, Savini I, Sabatini S (2011) Skeletal muscle differentiation: role of dehydroepiandrosterone sulfate. Horm Metab Res 43: 702\u2013707.","DOI":"10.1055\/s-0031-1285867"},{"key":"128","doi-asserted-by":"publisher","unstructured":"128 Min L, Yanase T, Tanaka T, Fan W, Nomura M, et al. (2009) A novel synthetic androgen receptor ligand, S42, works as a selective androgen receptor modulator and possesses metabolic effects with little impact on the prostate. Endocrinology 150: 5606\u20135616.","DOI":"10.1210\/en.2009-0405"},{"key":"129","doi-asserted-by":"crossref","unstructured":"129 Muta Y, Tanaka T, Hamaguchi Y, Hamanoue N, Motonaga R, et al. (2019) Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes. Biochem Biophys Rep 17: 177\u2013181.","DOI":"10.1016\/j.bbrep.2019.01.006"},{"key":"130","doi-asserted-by":"crossref","unstructured":"130 McArdle A, Dillmann WH, Mestril R, Faulkner JA, Jackson MJ (2004) Overexpression of HSP70 in mouse skeletal muscle protects against muscle damage and age-related muscle dysfunction. FASEB J 18: 355\u2013357.","DOI":"10.1096\/fj.03-0395fje"},{"key":"131","doi-asserted-by":"publisher","unstructured":"131 Nakashima N, Haji M, Sakai Y, Ono Y, Umeda F, et al. (1995) Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts. Metabolism 44: 543\u2013548.","DOI":"10.1016\/0026-0495(95)90065-9"},{"key":"132","doi-asserted-by":"crossref","unstructured":"132 Nakashima N, Haji M, Umeda F, Nawata H (1995) Effect of dehydroepiandrosterone on glucose uptake in cultured rat myoblasts. Horm Metab Res 27: 491\u2013494.","DOI":"10.1055\/s-2007-980009"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133 Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, et al. (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1: 69\u201373.","DOI":"10.1038\/271"},{"key":"134","doi-asserted-by":"crossref","unstructured":"134 Karishma KK, Herbert J (2002) Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 16: 445\u2013453.","DOI":"10.1046\/j.1460-9568.2002.02099.x"},{"key":"135","doi-asserted-by":"crossref","unstructured":"135 Phillips AC, Carroll D, Gale CR, Lord JM, Arlt W, et al. (2010) Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study. Eur J Endocrinol 163: 285\u2013292.","DOI":"10.1530\/EJE-10-0299"},{"key":"136","doi-asserted-by":"crossref","unstructured":"136 Phillips AC, Carroll D, Gale CR, Lord JM, Arlt W, et al. (2010) Cortisol, DHEAS, their ratio and the metabolic syndrome: evidence from the Vietnam Experience Study. Eur J Endocrinol 162: 919\u2013923.","DOI":"10.1530\/EJE-09-1078"},{"key":"137","doi-asserted-by":"crossref","unstructured":"137 Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale CR, et al. (2013) Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordr) 35: 963\u2013971.","DOI":"10.1007\/s11357-012-9396-8"},{"key":"138","doi-asserted-by":"crossref","unstructured":"138 Yanagita I, Fujihara Y, Kitajima Y, Tajima M, Honda M, et al. (2019) A high serum cortisol\/DHEA-S ratio is a risk factor for sarcopenia in elderly diabetic patients. J Endocr Soc 3: 801\u2013813.","DOI":"10.1210\/js.2018-00271"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139 Mueller C, Blum CA, Trummler M, Stolz D, Bingisser R, et al. (2014) Association of adrenal function and disease severity in community-acquired pneumonia. PLoS One 9: e99518.","DOI":"10.1371\/journal.pone.0099518"},{"key":"140","doi-asserted-by":"crossref","unstructured":"140 Blum CA, Mueller C, Schuetz P, Fluri F, Trummler M, et al. (2013) Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke. PLoS One 8: e63224.","DOI":"10.1371\/journal.pone.0063224"},{"key":"141","doi-asserted-by":"crossref","unstructured":"141 Tsai MH, Huang HC, Peng YS, Chen YC, Tian YC, et al. (2017) Dehydroepiandrosterone sulfate and dehydroepiandrosterone sulfate\/cortisol ratio in cirrhotic patients with septic shock: another sign of hepatoadrenal syndrome? Crit Care 21: 214.","DOI":"10.1186\/s13054-017-1768-0"},{"key":"142","doi-asserted-by":"crossref","first-page":"135","DOI":"10.32598\/IMMUNOREGULATION.3.2.5","volume":"3","author":"MRV Mahdavi","year":"2020","unstructured":"142 Mahdavi MRV, Ardestani SK, Rezaei A, Mohammadi S, Chenary MR, et al. (2020) COVID-19 patients suffer from DHEA-S sufficiency. Immunoregulation 3: 135\u2013144.","journal-title":"Immunoregulation","ISSN":"https:\/\/id.crossref.org\/issn\/2588-5200","issn-type":"print"},{"key":"143","doi-asserted-by":"crossref","unstructured":"143 Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, et al. (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9: 971\u2013988.","DOI":"10.1038\/nrd3295"},{"key":"144","doi-asserted-by":"crossref","unstructured":"144 Chung JY, Chen H, Midzak A, Burnett AL, Papadopoulos V, et al. (2013) Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged brown Norway rat Leydig cells. Endocrinology 154: 2156\u20132165.","DOI":"10.1210\/en.2012-2226"},{"key":"145","doi-asserted-by":"crossref","unstructured":"145 Murshid A, Eguchi T, Calderwood SK (2013) Stress proteins in aging and life span. Int J Hyperthermia 29: 442\u2013447.","DOI":"10.3109\/02656736.2013.798873"},{"key":"146","doi-asserted-by":"crossref","unstructured":"146 Uittenbogaard M, Baxter KK, Chiaramello A (2010) NeuroD6 genomic signature bridging neuronal differentiation to survival <i>via<\/i> the molecular chaperone network. J Neurosci Res 88: 33\u201354.","DOI":"10.1002\/jnr.22182"},{"key":"147","doi-asserted-by":"crossref","unstructured":"147 Oberbeck R, Deckert H, Bangen J, Kobbe P, Schmitz D (2007) Dehydroepiandrosterone: a modulator of cellular immunity and heat shock protein 70 production during polymicrobial sepsis. Intensive Care Med 33: 2207\u20132213.","DOI":"10.1007\/s00134-007-0851-4"},{"key":"148","unstructured":"148 Bernstein SL, Liu AM, Hansen BC, Somiari RI (2000) Heat shock cognate-70 gene expression declines during normal aging of the primate retina. Invest Ophthalmol Vis Sci 41: 2857\u20132862."},{"key":"149","doi-asserted-by":"crossref","unstructured":"149 Njemini R, Bautmans I, Onyema OO, Van Puyvelde K, Demanet C, et al. (2011) Circulating heat shock protein 70 in health, aging and disease. BMC Immunol 12: 24.","DOI":"10.1186\/1471-2172-12-24"},{"key":"150","doi-asserted-by":"crossref","unstructured":"150 Bobkova NV, Evgen\u2019ev M, Garbuz DG, Kulikov AM, Morozov A, et al. (2015) Exogenous Hsp70 delays senescence and improves cognitive function in aging mice. Proc Natl Acad Sci U S A 112: 16006\u201316011.","DOI":"10.1073\/pnas.1516131112"},{"key":"151","doi-asserted-by":"crossref","unstructured":"151 Zhang Y, Champagne N, Beitel LK, Goodyer CG, Trifiro M, et al. (2004) Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J Neurosci 24: 5315\u20135321.","DOI":"10.1523\/JNEUROSCI.0913-04.2004"},{"key":"152","doi-asserted-by":"crossref","unstructured":"152 El-Alfy M, Deloche C, Azzi L, Bernard BA, Bernerd F, et al. (2010) Skin responses to topical dehydroepiandrosterone: implications in antiageing treatment? Br J Dermatol 163: 968\u2013976.","DOI":"10.1111\/j.1365-2133.2010.09972.x"},{"key":"153","doi-asserted-by":"crossref","unstructured":"153 Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE (2010) The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci 31: 557\u2013566.","DOI":"10.1016\/j.tips.2010.08.007"},{"key":"154","doi-asserted-by":"publisher","unstructured":"154 Waterhouse RN, Chang RC, Atuehene N, Collier TL (2007) <i>In vitro<\/i> and <i>in vivo<\/i> binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPS. Synapse 61: 540\u2013546.","DOI":"10.1002\/syn.20369"},{"key":"155","doi-asserted-by":"crossref","unstructured":"155 Higuchi K, Nawata H, Maki T, Higashizima M, Kato K, et al. (1984) Prolactin has a direct effect on adrenal androgen secretion. J Clin Endocrinol Metab 59: 714\u2013718.","DOI":"10.1210\/jcem-59-4-714"},{"key":"156","doi-asserted-by":"crossref","unstructured":"156 Higuchi K, Nawata H, Kato K, Ibayashi H (1985) Ovine prolactin potentiates the action of adrenocorticotropic hormone on the secretion of dehydroepiandrosterone sulfate and dehydroepiandrosterone from cultured bovine adrenal cells. Horm Metab Res 17: 451\u2013453.","DOI":"10.1055\/s-2007-1013574"},{"key":"157","doi-asserted-by":"crossref","unstructured":"157 Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, et al. (2001) Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 144: 319\u2013329.","DOI":"10.1530\/eje.0.1440319"},{"key":"158","doi-asserted-by":"crossref","unstructured":"158 Ferrari E, Casarotti D, Muzzoni B, Albertelli N, Cravello L, et al. (2001) Age-related changes of the adrenal secretory pattern: possible role in pathological brain aging. Brain Res Brain Res Rev 37: 294\u2013300.","DOI":"10.1016\/S0165-0173(01)00133-3"},{"key":"159","doi-asserted-by":"crossref","unstructured":"159 Okabe T, Takayanagi R, Imasaki K, Haji M, Nawata H, et al. (1995) cDNA cloning of a NGFI-B\/nur77-related transcription factor from an apoptotic human T cell line. J Immunol 154: 3871\u20133879.","DOI":"10.4049\/jimmunol.154.8.3871"},{"key":"160","doi-asserted-by":"crossref","unstructured":"160 Okabe T, Takayanagi R, Adachi M, Imasaki K, Nawata H (1998) Nur77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells. J Endocrinol 156: 169\u2013175.","DOI":"10.1677\/joe.0.1560169"},{"key":"161","doi-asserted-by":"crossref","unstructured":"161 Ohashi M, Fujio N, Kato K, Nawata H, Ibayashi H (1986) Aging is without effect on the pituitary-adrenal axis in men. Gerontology 32: 335\u2013339.","DOI":"10.1159\/000212812"},{"key":"162","doi-asserted-by":"publisher","unstructured":"162 Ohashi M, Kato K, Nawata H, Ibayashi H (1986) Adrenocortical responsiveness to graded ACTH infusions in normal young and elderly human subjects. Gerontology 32: 43\u201351.","DOI":"10.1159\/000212764"},{"key":"163","doi-asserted-by":"crossref","unstructured":"163 Gupta D, Morley JE (2014) Hypothalamic-pituitary-adrenal (HPA) axis and aging. Compr Physiol 4: 1495\u20131510.","DOI":"10.1002\/cphy.c130049"},{"key":"164","doi-asserted-by":"crossref","unstructured":"164 Ueshiba H, Shimizu Y, Hiroi N, Yakushiji F, Shimojo M, et al. (2002) Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus. Eur J Endocrinol 146: 375\u2013380.","DOI":"10.1530\/eje.0.1460375"},{"key":"165","doi-asserted-by":"crossref","unstructured":"165 Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, et al. (2002) Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res 17: 979\u2013986.","DOI":"10.1359\/jbmr.2002.17.6.979"},{"key":"166","doi-asserted-by":"crossref","unstructured":"166 Hassan-Smith ZK, Morgan SA, Sherlock M, Hughes B, Taylor AE, et al. (2015) Gender-specific differences in skeletal muscle 11\u03b2-HSD1 expression across healthy aging. J Clin Endocrinol Metab 100: 2673\u20132681.","DOI":"10.1210\/jc.2015-1516"},{"key":"167","doi-asserted-by":"crossref","unstructured":"167 Tiganescu A, Walker EA, Hardy RS, Mayes AE, Stewart PM (2011) Localization, age- and site-dependent expression, and regulation of 11\u03b2-hydroxysteroid dehydrogenase type 1 in skin. J Invest Dermatol 131: 30\u201336.","DOI":"10.1038\/jid.2010.257"},{"key":"168","doi-asserted-by":"crossref","unstructured":"168 Lai HM, Liu MSY, Lin TJ, Tsai YL, Chien EJ (2017) Higher DHEAS levels associated with long-term practicing of Tai Chi. Chin J Physiol 60: 124\u2013130.","DOI":"10.4077\/CJP.2017.BAF454"},{"key":"169","doi-asserted-by":"crossref","unstructured":"169 Abdelhafiz AH, Sinclair AJ (2015) Low HbA1c and increased mortality risk-is frailty a confounding factor? Aging Dis 6: 262\u2013270.","DOI":"10.14336\/AD.2014.1022"},{"key":"170","unstructured":"170 Abdelhafiz AH, Loo BE, Hensey N, Bailey C, Sinclair A (2012) The U-shaped relationship of traditional cardiovascular risk factors and adverse outcomes in later life. Aging Dis 3: 454\u2013464."},{"key":"171","doi-asserted-by":"crossref","unstructured":"171 Hazeldine J, Arlt W, Lord JM (2010) Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol 120: 127\u2013136.","DOI":"10.1016\/j.jsbmb.2009.12.016"},{"key":"172","doi-asserted-by":"crossref","unstructured":"172 Smans LC, Souverein PC, Leufkens HG, Hoepelman AI, Zelissen PM (2013) Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study. Eur J Endocrinol 168: 609\u2013614.","DOI":"10.1530\/EJE-12-0879"},{"key":"173","doi-asserted-by":"crossref","unstructured":"173 Bancos I, Hazeldine J, Chortis V, Hampson P, Taylor AE, et al. (2017) Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol 176: 471\u2013480.","DOI":"10.1530\/EJE-16-0969"},{"key":"174","doi-asserted-by":"crossref","unstructured":"174 Solerte SB, Fioravanti M, Vignati G, Giustina A, Cravello L, et al. (1999) Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans <i>via<\/i> locally generated immunoreactive insulin-like growth factor I. J Clin Endocrinol Metab 84: 3260\u20133267.","DOI":"10.1210\/jc.84.9.3260"},{"key":"175","doi-asserted-by":"crossref","unstructured":"175 Suzuki T, Suzuki N, Daynes RA, Engleman EG (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61: 202\u2013211.","DOI":"10.1016\/S0090-1229(05)80024-8"},{"key":"176","doi-asserted-by":"crossref","unstructured":"176 Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, et al. (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man <i>in vitro<\/i>: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83: 2012\u20132017.","DOI":"10.1210\/jcem.83.6.4876"},{"key":"177","doi-asserted-by":"crossref","unstructured":"177 Wenisch C, Patruta S, Daxb\u00f6ck F, Krause R, H\u00f6rl W (2000) Effect of age on human neutrophil function. J Leukoc Biol 67: 40\u201345.","DOI":"10.1002\/jlb.67.1.40"},{"key":"178","unstructured":"178 Loria RM, Ben-Nathan D (2011) Protective effects of DHEA and AED against viral, bacterial and parasitic infections. Israel J Veterinary Med 66: 119\u2013130."},{"key":"179","doi-asserted-by":"crossref","first-page":"e13028","DOI":"10.1111\/acel.13028","volume":"18","author":"GM Fahy","year":"2019","unstructured":"179 Fahy GM, Brooke RT, Watson JP, Good Z, Vasanawala SS, et al. (2019) Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell 18: e13028.","journal-title":"Aging Cell","ISSN":"https:\/\/id.crossref.org\/issn\/1474-9718","issn-type":"print"},{"key":"180","doi-asserted-by":"crossref","unstructured":"180 Arlt W, Hammer F, Sanning P, Butcher SK, Lord JM, et al. (2006) Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. J Clin Endocrinol Metab 91: 2548\u20132554.","DOI":"10.1210\/jc.2005-2258"},{"key":"181","doi-asserted-by":"crossref","unstructured":"181 Foster MA, Taylor AE, Hill NE, Bentley C, Bishop J, et al. (2020) Mapping the steroid response to major trauma from injury to recovery: a prospective cohort study. J Clin Endocrinol Metab 105: 925\u2013937.","DOI":"10.1210\/clinem\/dgz302"},{"key":"182","doi-asserted-by":"crossref","unstructured":"182 Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR (2004) Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. Am J Physiol Endocrinol Metab 287: E731\u2013E738.","DOI":"10.1152\/ajpendo.00130.2004"},{"key":"183","doi-asserted-by":"crossref","unstructured":"183 McConnell KW, Fox AC, Clark AT, Chang NY, Dominguez JA, et al. (2011) The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. J Immunol 186: 3718\u20133725.","DOI":"10.4049\/jimmunol.1003652"},{"key":"184","doi-asserted-by":"crossref","unstructured":"184 Vulczak A, Catal\u00e3o CHR, Freitas LAP, Rocha MJA (2019) HSP-Target of therapeutic agents in sepsis treatment. Int J Mol Sci 20: 4255.","DOI":"10.3390\/ijms20174255"},{"key":"185","doi-asserted-by":"crossref","unstructured":"185 Bentley C, Hazeldine J, Greig C, Lord J, Foster M (2019) Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient. Burns Trauma 7: 26.","DOI":"10.1186\/s41038-019-0158-z"},{"key":"186","doi-asserted-by":"crossref","unstructured":"186 Yanase T, Yanagita I, Muta K, Nawata H (2018) Frailty in elderly diabetes patients. Endocr J 65: 1\u201311.","DOI":"10.1507\/endocrj.EJ17-0390"},{"key":"187","doi-asserted-by":"crossref","unstructured":"187 Leng SX, Cappola AR, Andersen RE, Blackman MR, Koenig K, et al. (2004) Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16: 153\u2013157.","DOI":"10.1007\/BF03324545"},{"key":"188","doi-asserted-by":"crossref","unstructured":"188 Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM (2009) The association between dehydroepiandosterone and frailty in older men and women. Age Ageing 38: 401\u2013406.","DOI":"10.1093\/ageing\/afp015"},{"key":"189","doi-asserted-by":"crossref","unstructured":"189 Swiecicka A, Lunt M, Ahern T, O\u2019Neill TW, Bartfai G, et al. (2017) Nonandrogenic anabolic hormones predict risk of frailty: european male ageing study prospective data. J Clin Endocrinol Metab 102: 2798\u20132806.","DOI":"10.1210\/jc.2017-00090"},{"key":"190","doi-asserted-by":"crossref","unstructured":"190 Forti P, Maltoni B, Olivelli V, Pirazzoli GL, Ravaglia G, et al. (2012) Serum dehydroepiandrosterone sulfate and adverse health outcomes in older men and women. Rejuvenation Res 15: 349\u2013358.","DOI":"10.1089\/rej.2011.1248"},{"key":"191","doi-asserted-by":"crossref","unstructured":"191 Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, et al. (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56: M146\u2013M156.","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"192","doi-asserted-by":"crossref","unstructured":"192 Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, et al. (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173: 489\u2013495.","DOI":"10.1503\/cmaj.050051"},{"key":"193","doi-asserted-by":"crossref","unstructured":"193 Yanagita I, Fujihara Y, Eda T, Tajima M, Yonemura K, et al. (2018) Low glycated hemoglobin level is associated with severity of frailty in Japanese elderly diabetes patients. J Diabetes Investig 9: 419\u2013425.","DOI":"10.1111\/jdi.12698"},{"key":"194","doi-asserted-by":"crossref","unstructured":"194 Yanagita I, Fujihara Y, Iwaya C, Kitajima Y, Tajima M, et al. (2020) Low serum albumin, aspartate aminotransferase, and body mass are risk factors for frailty in elderly people with diabetes-a cross-sectional study. BMC Geriatr 20: 200.","DOI":"10.1186\/s12877-020-01601-z"},{"key":"195","doi-asserted-by":"crossref","unstructured":"195 Sumida Y, Naito Y, Hashimoto E, Aoi W, Takahashi Y, et al. (2012) Science of nonalcoholic fatty liver diseases in anti-aging medicine 2011. Anti-Aging Med 9: 24\u201333.","DOI":"10.3793\/jaam.9.24"},{"key":"196","doi-asserted-by":"crossref","unstructured":"196 Hakkak R, Bell A, Korourian S (2017) Dehydroepiandrosterone (DHEA) feeding protects liver steatosis in obese breast cancer rat model. Sci Pharm 85: 13.","DOI":"10.3390\/scipharm85010013"},{"key":"197","doi-asserted-by":"publisher","unstructured":"197 Fukui M, Ose H, Nakayama I, Hosoda H, Asano M, et al. (2007) Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentrations in women with type 2 diabetes. Diabetes Care 30: 1886\u20131888.","DOI":"10.2337\/dc06-2325"},{"key":"198","doi-asserted-by":"crossref","unstructured":"198 Ravaglia G, Forti P, Maioli F, Boschi F, Bernardi M, et al. (1996) The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab 81: 1173\u20131178.","DOI":"10.1210\/jcem.81.3.8772596"},{"key":"199","unstructured":"199 Haffner SM, Valdez RA, Stern MP, Katz MS (1993) Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord 17: 643\u2013649."},{"key":"200","doi-asserted-by":"crossref","unstructured":"200 Yamada M, Moriguch Y, Mitani T, Aoyama T, Arai H (2014) Age-dependent changes in skeletal muscle mass and visceral fat area in Japanese adults from 40 to 79 years-of-age. Geriatr Gerontol Int 14 Suppl 1: 8\u201314.","DOI":"10.1111\/ggi.12209"},{"key":"201","doi-asserted-by":"crossref","unstructured":"201 Valenti G, Denti L, Maggio M, Ceda G, Volpato S, et al. (2004) Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59: 466\u2013472.","DOI":"10.1093\/gerona\/59.5.M466"},{"key":"202","doi-asserted-by":"crossref","unstructured":"202 Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, et al. (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15: 95\u2013101.","DOI":"10.1016\/j.jamda.2013.11.025"},{"key":"203","doi-asserted-by":"crossref","unstructured":"203 Aizawa K, Iemitsu M, Maeda S, Jesmin S, Otsuki T, et al. (2007) Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats. Am J Physiol Endocrinol Metab 292: E577\u2013E584.","DOI":"10.1152\/ajpendo.00367.2006"},{"key":"204","doi-asserted-by":"crossref","unstructured":"204 Sato K, Iemitsu M (2015) Exercise and sex steroid hormones in skeletal muscle. J Steroid Biochem Mol Biol 145: 200\u2013205.","DOI":"10.1016\/j.jsbmb.2014.03.009"},{"key":"205","doi-asserted-by":"crossref","unstructured":"205 Sato K, Iemitsu M, Matsutani K, Kurihara T, Hamaoka T, et al. (2014) Resistance training restores muscle sex steroid hormone steroidogenesis in older men. FASEB J 28: 1891\u20131897.","DOI":"10.1096\/fj.13-245480"},{"key":"206","doi-asserted-by":"publisher","unstructured":"206 Sugino M, Ohsawa N, Ito T, Ishida S, Yamasaki H, et al. (1998) A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Neurology 51: 586\u2013589.","DOI":"10.1212\/WNL.51.2.586"},{"key":"207","doi-asserted-by":"crossref","unstructured":"207 Villareal DT, Holloszy JO (2006) DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. Am J Physiol Endocrinol Metab 291: E1003\u2013E1008.","DOI":"10.1152\/ajpendo.00100.2006"},{"key":"208","doi-asserted-by":"crossref","unstructured":"208 Kenny AM, Boxer RS, Kleppinger A, Brindisi J, Feinn R, et al. (2010) Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc 58: 1707\u20131714.","DOI":"10.1111\/j.1532-5415.2010.03019.x"},{"key":"209","doi-asserted-by":"crossref","unstructured":"209 Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, et al. (2008) Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 93: 400\u2013409.","DOI":"10.1210\/jc.2007-1134"},{"key":"210","doi-asserted-by":"crossref","unstructured":"210 Jankowski CM, Wolfe P, Schmiege SJ, Nair KS, Khosla S, et al. (2019) Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: a pooled analysis of four clinical trials. Clin Endocrinol (Oxf) 90: 293\u2013300.","DOI":"10.1111\/cen.13901"},{"key":"211","doi-asserted-by":"crossref","unstructured":"211 Nawata H, Tanaka S, Tanaka S, Takayanagi R, Sakai Y, et al. (1995) Aromatase in bone cell: association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 53: 165\u2013174.","DOI":"10.1016\/0960-0760(95)00031-T"},{"key":"212","doi-asserted-by":"crossref","unstructured":"212 Tanaka S, Haji M, Nishi Y, Yanase T, Takayanagi R, et al. (1993) Aromatase activity in human osteoblast-like osteosarcoma cell. Calcif Tissue Int 52: 107\u2013109.","DOI":"10.1007\/BF00308318"},{"key":"213","doi-asserted-by":"publisher","unstructured":"213 Tanaka S, Haji M, Takayanagi R, Tanaka S, Sugioka Y, et al. (1996) 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts. Endocrinology 137: 1860\u20131869.","DOI":"10.1210\/en.137.5.1860"},{"key":"214","doi-asserted-by":"crossref","unstructured":"214 Yanase T, Suzuki S, Goto K, Nomura M, Okabe T, et al. (2003) Aromatase in bone: roles of Vitamin D3 and androgens. J Steroid Biochem Mol Biol 86: 393\u2013397.","DOI":"10.1016\/S0960-0760(03)00349-2"},{"key":"215","doi-asserted-by":"crossref","unstructured":"215 Liang X, Glowacki J, Hahne J, Xie L, LeBoff MS, et al. (2016) Dehydroepiandrosterone stimulation of osteoblastogenesis in human MSCs requires IGF-I signaling. J Cell Biochem 117: 1769\u20131774.","DOI":"10.1002\/jcb.25475"},{"key":"216","doi-asserted-by":"crossref","unstructured":"216 Yokomoto-Umakoshi M, Umakoshi H, Iwahashi N, Matsuda Y, Kaneko H, et al. (2021) Protective role of DHEAS in age-related changes in bone mass and fracture risk. J Clin Endocrinol Metab 106: e4580\u2013e4592.","DOI":"10.1210\/clinem\/dgab459"},{"key":"217","doi-asserted-by":"crossref","unstructured":"217 Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, et al. (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 23: 105\u2013109.","DOI":"10.1007\/s00774-004-0596-x"},{"key":"218","doi-asserted-by":"crossref","unstructured":"218 Suzuki Y, Nawata H, Soen S, Fujiwara S, Nakayama H, et al. (2014) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab 32: 337\u2013350.","DOI":"10.1007\/s00774-014-0586-6"},{"key":"219","doi-asserted-by":"crossref","unstructured":"219 Harding G, Mak YT, Evans B, Cheung J, MacDonald D, et al. (2006) The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA. Cytokine 36: 57\u201368.","DOI":"10.1016\/j.cyto.2006.10.012"},{"key":"220","unstructured":"220 Wang YD, Wang L, Li DJ, Wang WJ (2006) Dehydroepiandrosterone inhibited the bone resorption through the upregulation of OPG\/RANKL. Cell Mol Immunol 3: 41\u201345."},{"key":"221","unstructured":"221 Mease PJ, Ginzler EM, Gluck OS, Schiff M, Goldman A, et al. (2005) Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy. J Rheumatol 32: 616\u2013621."},{"key":"222","doi-asserted-by":"crossref","unstructured":"222 Arlt W (2009) The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 94: 1059\u20131067.","DOI":"10.1210\/jc.2009-0032"},{"key":"223","doi-asserted-by":"crossref","unstructured":"223 Takayanagi R, Miura K, Nakagawa H, Nawata H (2000) Epidemiologic study of adrenal gland disorders in Japan. Biomed Pharmacother 54 Suppl 1: 164s\u2013168s.","DOI":"10.1016\/S0753-3322(00)80036-0"},{"key":"224","doi-asserted-by":"crossref","unstructured":"224 Erichsen MM, L\u00f8v\u00e5s K, Fougner KJ, Svartberg J, Hauge ER, et al. (2009) Normal overall mortality rate in Addison\u2019s disease, but young patients are at risk of premature death. Eur J Endocrinol 160: 233\u2013237.","DOI":"10.1530\/EJE-08-0550"},{"key":"225","doi-asserted-by":"crossref","unstructured":"225 Grodstein E, Hardy MA, Goldstein MJ (2010) A case of human intramuscular adrenal gland transplantation as a cure for chronic adrenal insufficiency. Am J Transplant 10: 431\u2013433.","DOI":"10.1111\/j.1600-6143.2009.02929.x"},{"key":"226","doi-asserted-by":"crossref","unstructured":"226 Morohashi KI, Omura T (1996) Ad4BP\/SF-1, a transcription factor essential for the transcription of steroidogenic cytochrome P450 genes and for the establishment of the reproductive function. FASEB J 10: 1569\u20131577.","DOI":"10.1096\/fasebj.10.14.9002548"},{"key":"227","doi-asserted-by":"crossref","unstructured":"227 Gondo S, Yanase T, Okabe T, Tanaka T, Morinaga H, et al. (2004) SF-1\/Ad4BP transforms primary long-term cultured bone marrow cells into ACTH-responsive steroidogenic cells. Genes Cells 9: 1239\u20131247.","DOI":"10.1111\/j.1365-2443.2004.00801.x"},{"key":"228","doi-asserted-by":"crossref","unstructured":"228 Tanaka T, Gondo S, Okabe T, Ohe K, Shirohzu H, et al. (2007) Steroidogenic factor 1\/adrenal 4 binding protein transforms human bone marrow mesenchymal cells into steroidogenic cells. J Mol Endocrinol 39: 343\u2013350.","DOI":"10.1677\/JME-07-0076"},{"key":"229","doi-asserted-by":"publisher","unstructured":"229 Gondo S, Okabe T, Tanaka T, Morinaga H, Nomura M, et al. (2008) Adipose tissue-derived and bone marrow-derived mesenchymal cells develop into different lineage of steroidogenic cells by forced expression of steroidogenic factor 1. Endocrinology 149: 4717\u20134725.","DOI":"10.1210\/en.2007-1808"},{"key":"230","doi-asserted-by":"crossref","unstructured":"230 Tanaka T, Aoyagi C, Mukai K, Nishimoto K, Kodama S, et al. (2020) Extension of survival in bilaterally adrenalectomized mice by implantation of SF-1\/Ad4BP-induced steroidogenic cells. Endocrinology 161: bqaa007.","DOI":"10.1210\/endocr\/bqaa007"},{"key":"231","doi-asserted-by":"publisher","unstructured":"231 Yazawa T, Mizutani T, Yamada K, Kawata H, Sekiguchi T, et al. (2006) Differentiation of adult stem cells derived from bone marrow stroma into Leydig or adrenocortical cells. Endocrinology 147: 4104\u20134111.","DOI":"10.1210\/en.2006-0162"},{"key":"232","doi-asserted-by":"crossref","unstructured":"232 Sonoyama T, Sone M, Honda K, Taura D, Kojima K, et al. (2012) Differentiation of human embryonic stem cells and human induced pluripotent stem cells into steroid-producing cells. Endocrinology 153: 4336\u20134345.","DOI":"10.1210\/en.2012-1060"},{"key":"233","doi-asserted-by":"crossref","unstructured":"233 Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, et al. (2018) Modeling congenital adrenal hyperplasia and testing interventions for adrenal insufficiency using donor-specific reprogrammed cells. Cell Rep 22: 1236\u20131249.","DOI":"10.1016\/j.celrep.2018.01.003"},{"key":"234","doi-asserted-by":"crossref","unstructured":"234 Steenblock C, Rubin de Celis MF, Delgadillo Silva LF, Pawolski V, Brennand A, et al. (2018) Isolation and characterization of adrenocortical progenitors involved in the adaptation to stress. Proc Natl Acad Sci U S A 115: 12997\u201313002.","DOI":"10.1073\/pnas.1814072115"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/4\/73_EJ25-0483\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:26:32Z","timestamp":1775273192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/4\/73_EJ25-0483\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":234,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0483","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0483"}}